Regression of stroke-like lesions in MELAS-syndrome after seizure control

Epileptic Disorders

Volumn 12, Issue 4, 2010, Pages 330-334

  Finsterer, Josef ^a   Barton, Peter ^b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b Institute of Radiology Urania   (Austria)

Author keywords

Antiepileptics; Epilepsy; MELAS; Metabolic disease; Mitochondrial disorders; Seizures

Indexed keywords

LAMOTRIGINE; LORAZEPAM; VALPROIC ACID; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE;

ADULT; ANOSMIA; CASE REPORT; CAUDATE NUCLEUS; COMPLEX PARTIAL SEIZURE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPTIC AURA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE MUTATION; GRAND MAL SEIZURE; HEADACHE; HEMIANOPIA; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERVENTILATION; IRON METABOLISM DISORDER; MELAS SYNDROME; MICROCYTIC ANEMIA; MIGRAINE; MUSCLE ATROPHY; MYOPATHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PRIORITY JOURNAL; SHORT STATURE; SPEECH DISORDER; STROKE; TASTE DISORDER; TEMPORAL CORTEX; TONIC CLONIC SEIZURE; VERTIGO; VISUAL FIELD DEFECT; VISUAL HALLUCINATION; WHITE MATTER; ARTICLE; BRAIN CORTEX; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; REMISSION; SEIZURE; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LORAZEPAM; MAGNETIC RESONANCE IMAGING; MELAS SYNDROME; REMISSION INDUCTION; SEIZURES; TREATMENT OUTCOME; TRIAZINES;

EID: 79952462096     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2010.0338     Document Type: Note

References (13)

1. Deschauer M, Tennant S, Rokicka A, He L, Kraya T, Turnbull DM, et al. MELAS associated with mutations in the POLG1 gene. Neurology 2007; 68: 1741-2. (Pubitemid 46763266)
2. Finsterer J, Segall L. Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 2010; 33: 138-51.
3. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007; 116: 1-14. (Pubitemid 46976273)
4. Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003; 61: 1238-44. (Pubitemid 37377544)
5. Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002; 59: 816-24.
6. Ishikawa N, Tajima G, Ono H, Kobayashi M. Different neuroradiological findings during two stroke-like-episodes in a patient with a congenital disorder of glycosylation type Ia. Brain Dev 2009; 31: 240-3.
7. Ito H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like-episodes in MELAS. Brain Dev 2008; 30: 483-8.
8. Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M. Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev 2004; 26: 481-3. (Pubitemid 39209388)
9. Lin CM, Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 2007; 22: 105-9. (Pubitemid 46354826)
10. Ohshita T, Oka M, Imon Y, Watanabe C, Katayama S, Yamaguchi S, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000; 42: 651-6.
11. Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Arch Neurol 2010; 67: 19-24.
12. Toth G, Morava E, Bene J, Selhorst JJ, Overmars H, Vreken P, et al. Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993T>C mutation associated Leigh syndrome. J Inherit Metab Dis 2001; 24: 421-2. (Pubitemid 32677529)
13. Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like-episodes. Stroke 2009; 40: e15-7.